CTOs on the Move


 
Stago is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.stago.com
  • 5 Century Dr
    Parsippany, NJ USA 07054
  • Phone: 888.291.0415

Executives

Name Title Contact Details

Similar Companies

Oridion

Oridion is a Needham Heights, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

BERCHTOLD Corporation

BERCHTOLD Corporation is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Intelligent Hospital Systems (IH Systems)

Intelligent Hospital Systems (IH Systems) is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Viz

In 2015, five seminal randomized controlled trials were published in the neurovascular space demonstrating endovascular thrombectomy to be the new gold standard for treating large vessel occlusion strokes. During that same year, advancements in artificial intelligence and deep learning made it possible to analyze medical imaging rapidly and accurately. However, despite having proven effective interventions for stroke, most stroke patients were getting treatment late or not at all. At Stanford University, Dr. Chris Mansi (neurosurgeon) and Dr. David Golan (machine learning researcher) identified this problem and together they sought to change it.

Lensar

LENSAR, Inc. is a global leader in next-generation femtosecond laser technology for refractive cataract surgery. The LENSAR Laser System offers cataract surgeons precision, accuracy, and efficiency while optimizing overall visual outcomes. LENSAR`s proprietary Augmented Reality technology -- reconstructed 3-D imaging, measurement, and guidance system -- offers quick and easy patient docking and provides high-resolution ocular images in a single scan. This technology facilitates enhanced procedure outcomes by allowing the physician to develop individualized treatment plans including precise laser delivery, and efficient lens fragmentation that can reduce, and potentially eliminate phaco energy. The LENSAR Laser System also offers the industry`s smallest laser footprint and thoughtful ergonomic design that accommodates most operating rooms. The LENSAR Laser System has been cleared by FDA for anterior capsulotomy, lens fragmentation, and corneal and arcuate incisions. For other indications it is an investigational device limited by U.S. law to investigational use only